Mackay Shields LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mackay Shields LLC's LLY Position: Q2 2022 in Review
Mackay Shields LLC sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 114,222 shares — an estimated $32.7M sold.
Mackay Shields LLC first reported a position in LLY in Q1 2018 and held it in 17 quarters. The position peaked at $44M in Q1 2018. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Mackay Shields LLC reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
- Mackay Shields LLC sold 114,222 Eli Lilly shares in Q2 2022, an estimated $32.7M.
- Mackay Shields LLC first reported a position in Eli Lilly in Q1 2018 and held it in 17 quarters.
- Mackay Shields LLC's Eli Lilly position peaked at $44M in Q1 2018.
- 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.